Andres Salmeron

Dr. Andres Salmeron is a trained immunologist with expertise in immuno-oncology and inflammation. He has 20 years of experience in small-molecule and biologics drug discovery in both the pharmaceutical and biotechnology industries. Most recently, Dr. Salmeron served as Senior Director of Immunology at Potenza Therapeutics until its acquisition by Astellas Pharmaceuticals in 2018. Prior to Potenza, he worked as a scientist/manager at Constellation Pharmaceuticals and Abbott Laboratories.

Dr. Salmeron is a graduate of the Universidad Autonoma in Madrid, Spain with a B.S. in Biochemistry and Molecular Biology and a Ph.D. in Immunology. He continued his training as a postdoctoral fellow at the National Institute for Medical Research in Mill Hill, London.